AMCINONIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amcinonide, and what generic alternatives are available?
Amcinonide is a drug marketed by Genus Lifesciences, Taro Pharm Inds, Solubiomix, and Genus. and is included in five NDAs.
The generic ingredient in AMCINONIDE is amcinonide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amcinonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amcinonide
A generic version of AMCINONIDE was approved as amcinonide by TARO PHARM INDS on May 31st, 2002.
US Patents and Regulatory Information for AMCINONIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genus Lifesciences | AMCINONIDE | amcinonide | CREAM;TOPICAL | 076065-001 | May 15, 2003 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Genus | AMCINONIDE | amcinonide | OINTMENT;TOPICAL | 076096-001 | Nov 19, 2002 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Taro Pharm Inds | AMCINONIDE | amcinonide | CREAM;TOPICAL | 076229-001 | May 31, 2002 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
